Pacira BioSciences (PCRX) Stock Chart & Stock Price History $24.88 -0.09 (-0.36%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$24.88 0.00 (0.00%) As of 04/15/2025 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pacira BioSciences Stock Price Performance 5 Day Performance+1.30%1 Month Performance+8.79%3 Month Performance+12.78%6 Month Performance+49.61%Year-To-Date Performance+32.06%1 Year Performance-7.41% Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PCRX Stock Chart for Wednesday, April, 16, 2025 PCRX Chart by TradingViewRemove Ads Pacira BioSciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/15/2025$24.97$24.88-0.36%$25.14$24.30503,440 shs$1.15 billion04/14/2025$24.56$24.97+1.67%$25.35$24.36997,901 shs$1.16 billion04/11/2025$23.69$24.56+3.67%$24.57$23.62605,564 shs$1.14 billion04/10/2025$25.84$23.69-8.32%$25.56$22.421.46 million shs$1.10 billion04/09/2025$26.27$25.84-1.64%$26.02$22.122.73 million shs$1.20 billion04/09/2025$26.27$25.84-1.64%$26.02$22.122.73 million shs$1.20 billion04/08/2025$22.91$26.27+14.67%$27.64$25.513.72 million shs$1.22 billion04/08/2025$22.91$26.27+14.67%$27.64$25.513.72 million shs$1.22 billion04/07/2025$23.10$22.91-0.82%$24.17$21.79979,940 shs$1.06 billion04/04/2025$24.29$23.10-4.90%$24.03$22.63692,277 shs$1.07 billion Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 04/03/2025$24.89$24.29-2.41%$24.64$24.12641,711 shs$1.12 billion04/02/2025$24.07$24.89+3.41%$24.93$23.66452,799 shs$1.15 billion04/01/2025$24.85$24.07-3.14%$24.84$23.99640,652 shs$1.11 billion03/31/2025$24.91$24.85-0.24%$25.20$24.38607,871 shs$1.15 billion03/28/2025$25.30$24.91-1.54%$25.88$24.52586,571 shs$1.15 billion03/27/2025$24.42$25.30+3.60%$25.36$24.38803,782 shs$1.17 billion03/26/2025$24.54$24.42-0.49%$24.93$24.111.24 million shs$1.13 billion03/25/2025$24.84$24.54-1.21%$24.83$23.931.33 million shs$1.14 billion03/24/2025$24.14$24.84+2.90%$25.08$24.121.03 million shs$1.15 billion03/21/2025$23.82$24.14+1.34%$24.25$23.533.11 million shs$1.12 billion03/20/2025$24.28$23.82-1.89%$24.37$23.74519,211 shs$1.10 billion03/19/2025$23.67$24.28+2.58%$24.33$23.70495,172 shs$1.12 billion03/18/2025$23.31$23.67+1.54%$24.04$22.56543,080 shs$1.08 billion03/17/2025$22.87$23.31+1.92%$23.52$23.07613,176 shs$1.08 billion Related Companies Perrigo Stock Chart Supernus Pharmaceuticals Stock Chart Omeros Stock Chart Nektar Therapeutics Stock Chart Assembly Biosciences Stock Chart Cumberland Pharmaceuticals Stock Chart Eli Lilly and Company Stock Chart Johnson & Johnson Stock Chart AbbVie Stock Chart Merck & Co., Inc. Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
